
-
2013
Company Description
Myelo Therapeutics GmbH develops innovative treatments in areas of high unmet medical needs.
Myelo Therapeutics is focused on the development of treatments for a range of medical needs. It offers myelo001, a molecule that is effective on the hematogenesis. Myelo Therapeutics was founded by Till Erdmann in 2013. It is based in Berlin, Germany.
-
Manufacturer:
Information Technology -
Formed:
2013 -
Founders:
Till Erdmann -
Company Website:
-
Company E-mail:
-
Company Address:
Kastanienallee 56BerlinGermany -
CEO:
- Till Erdmann
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits